Cipla Health Ltd., one of India's most trusted fast-moving wellness goods (FMWG) companies, has announced the launch of ...

COIMBATORE: Officials of the Drug Administration Department and Food Safety Department have instructed pharmacies not to recommend electrolyte drinks, such as ORSL, to patients, instead of ORS (Oral ...

is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective serotonin reuptake inhibitor (SSRI) developed to treat a range of mental ...

Managing diabetes during summer is not just about controlling carbohydrates or skipping desserts, fruit, and other sweets ...

Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective serotonin reuptake inhibitor (SSRI ...

Electrolytes are having a moment in Australia – whether it’s powders, ready-to-drink beverages or gummies – and it seems they ...

Credit: Caleb Woods on Unsplash. Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a ...

DEER PARK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and ...

HAUPPAUGE, N.Y.--(BUSINESS WIRE)--#Depression--Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective ...

On May 28, 2025, the FDA approved Eton Pharmaceuticals' new drug application (NDA) for hydrocortisone oral solution (Khindivi) as a replacement therapy for pediatric patients aged 5 years or older ...

Credit: Eton. Khindivi is expected to be available the week of June 2, 2025. Khindivi is the first FDA-approved hydrocortisone oral solution. The Food and Drug Administration (FDA) has approved ...